-
公开(公告)号：KR1020090039230A
公开(公告)日：2009-04-22
申请号：KR1020070104736
申请日：2007-10-17
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N7/00
Abstract: A new vaccine to duck hepatitis virus is provided to have excellence in resistance against epidemic duck hepatitis and lessen damage caused by the duck hepatitis. A method for producing vaccine(deposition No. KCCM10883P) of duck hepatitis virus having sequence of sequence No. 1 [SEQ ID NO:1] comprises: a step of diluting recently epidemic duck hepatitis virus in phosphate buffer; a step of inoculating 7-9 days old chicken embryo; a step of culturing the inoculated chicken embryo at 37°C for three days; and a step of collecting the cultured chicken embryo and performing subculture sequencially to adapt the chicken embryo. A process for manufacturing a new vaccine is performed with: the step of attenuating the duck hepatitis virus; a step of testing restoration of attenuated virus; a step of searching defense ability of vaccine to selected duck hepatitis virus; a step of searching defense ability in each pathway; a step of searching minimum amount of the vaccine; and a step of safety and amount of the vaccine.
Abstract translation: 提供了一种新型的鸭肝炎病毒疫苗，具有卓越的抗流行性鸭肝炎防治能力，减轻了鸭肝炎所造成的伤害。 具有序列号1 [SEQ ID NO：1]序列的鸭肝炎病毒疫苗（沉积编号KCCM10883P）的制备方法包括：在磷酸盐缓冲液中稀释近期流行的鸭肝炎病毒的步骤; 接种7-9天龄鸡胚的步骤; 将接种的鸡胚在37℃培养3天的步骤; 并收集培养的鸡胚并顺序进行亚文化以适应鸡胚的步骤。 制备新疫苗的方法是：减毒鸭肝炎病毒的步骤; 测试减毒病毒恢复的一个步骤; 检测疫苗对选择的鸭肝炎病毒的防御能力的一个步骤; 在每个途径中寻找防御能力的一个步骤; 搜索最少量的疫苗的步骤; 和疫苗的安全和数量的步骤。
-
公开(公告)号：KR100834026B1
公开(公告)日：2008-06-02
申请号：KR1020070001888
申请日：2007-01-08
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
CPC classification number: A61K39/0208 , C07K14/195
Abstract: A riemerella vaccine for preventing riemerella infection is provided to defend the infection of field pathogenic Riemerella anatipestifer which occurs frequently in a country and prevent ducks from being perished by the riemerella infection, thereby minimizing economical loss of a duck industry. A riemerella vaccine for preventing riemerella infection comprises an inactivated Riemerella anatipestifer and an immuno-enhancing agent, wherein the inactivated Riemerella anatipestifer is a strain selected from the group consisting of serovar type I, serovar type IV, serovar type VII, serovar type XVI and a mixture strain thereof. A method for preparing the riemerella vaccine comprises the steps of: (a) culturing Riemerella anatipestifer isolated from a suck; (b) adding an inactivating agent such as 0.3% formalized physiological saline solution(FPSS) to a culture solution obtained from the step(a) to inactivate the Riemerella anatipestifer; and (c) adding an immuno-enhancing agent to the inactivated Riemerella anatipestifer culture solution to prepare a mixture vaccine. Further, the immuno-enhancing agent is ISA70.
Abstract translation: 提供了一种用于预防痢疾杆菌感染的雷米他菌疫苗，用于捍卫一个国家频繁发生的野外致病性雷米他氏菌感染，并防止鸭子被莱梅里埃菌感染消灭，从而最大限度地减少了鸭业的经济损失。 用于预防雷米他里亚感染的莱米诺菌素疫苗包括灭活的雷米他氏菌和免疫增强剂，其中所述灭活的雷米他氏菌是选自I型血清型，IV型血清型，VII型血清型，血清型XVI和 其混合应变。 一种制备莱米酵母疫苗的方法包括以下步骤：（a）培养从吸吮物分离的烟草雷蒙酵母; （b）将灭活剂如0.3％正规化生理盐水溶液（FPSS）加入到从步骤（a）获得的培养溶液中以灭活烟草雷蒙酵母; 和（c）向灭活的雷神雷公藤培养液中加入免疫增强剂以制备混合疫苗。 此外，免疫增强剂是ISA70。
-
公开(公告)号：KR101207213B1
公开(公告)日：2012-12-13
申请号：KR1020090114269
申请日：2009-11-25
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C12N5/10 , C12N15/12 , C12N15/867
CPC classification number: C12N7/00 , C12N2740/15043 , C12N2790/10051
Abstract: 본발명은전염성해면상뇌증의전염성해면상뇌증(TSE; transmissible spongiform encephalopathy) 감수성세포의제조방법및 그방법에의해서수득된감수성세포의활용에관한것으로, 본발명에의해서수득되는전염성해면상뇌증감수성세포는전염성해면상뇌증의진단, 병인론및 신약개발등에유리하게활용될수 있다.
-
公开(公告)号：KR1020120075677A
公开(公告)日：2012-07-09
申请号：KR1020100137437
申请日：2010-12-29
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K36/288 , A61P25/28 , A61P25/00
Abstract: PURPOSE: A composition containing Taraxacum officinale extract is provided to suppress BSE-modified prion production or remove the prion and to prevent or treat BSE. CONSTITUTION: A veterinary composition for preventing or treating BSE contains Taraxacum officinale extract. The composition is manufactured in the form of powder, granules, capsules, suspension, emulsion, solution, syrup, aerosol, soft or hard gelatin capsule, suppository, sterilized injection solution, and sterilized external use formulation. The extract is prepared using water, low carbon number alcohol of C1-C4, and a mixture solvent thereof. A feed additive composition for preventing or treating BSE contains the extract.
Abstract translation: 目的：提供含有蒲公英提取物的组合物以抑制BSE修饰的朊病毒产生或去除朊病毒并预防或治疗疯牛病。 组成：用于预防或治疗疯牛病的兽用组合物含有蒲公英提取物。 组合物以粉末，颗粒，胶囊，悬浮液，乳液，溶液，糖浆，气溶胶，软或硬明胶胶囊，栓剂，灭菌注射溶液和灭菌外用制剂的形式制造。 提取物是使用C1-C4的低碳数醇及其混合溶剂制备的。 用于预防或治疗BSE的饲料添加剂组合物含有提取物。
-
公开(公告)号：KR1020110009967A
公开(公告)日：2011-01-31
申请号：KR1020090067436
申请日：2009-07-23
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: PURPOSE: A monoclonal antibody for specifically detecting abnormal prion of spongiform encephalopathy is provided. CONSTITUTION: A fusion cell line of deposit number KCLRF-BP-00213 produces monoclonal antibody for detecting abnormal prion of spongiform encephalopathy. A method for preparing fusion cell line comprises: a step of inoculating a peptide of sequence number 1 to a knock-out mouse; a step of isolating B cells from the mouse; and a step of fusing the B cells and mouse myeloma-derived cells. The abnormal prion of spongiform encephalopathy is detected by western blotting using the monoclonal antibody.
Abstract translation: 目的：提供特异性检测海绵状脑病异常朊病毒的单克隆抗体。 构成：存在编号为KCLRF-BP-00213的融合细胞系产生用于检测海绵状脑病异常朊病毒的单克隆抗体。 制备融合细胞系的方法包括：将序列号1的肽接种到敲除小鼠的步骤; 从小鼠中分离出B细胞的步骤; 以及融合B细胞和小鼠骨髓源性细胞的步骤。 使用单克隆抗体通过western印迹检测海绵状脑病的异常朊病毒。
-
Patent Agency Ranking6.发明公开
公开(公告)号：KR1020140081447A
公开(公告)日：2014-07-01
申请号：KR1020120151209
申请日：2012-12-21
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: The present invention relates to an expression vector comprising a gene encoding a prion protein of Capra hircus and a cell transduced by the vector. The present invention can be used for manufacturing a cell having polymorphism, which represents Capra hircus bred in Korea, and a transduced mouse; and can be effectively used for developing an animal experimental model for studies including diagnosis of prion diseases which include scrapie occurred in goat family animals, and for confirming if domestic TSE diseases interspecifically spread or not.
Abstract translation: 本发明涉及一种表达载体，其包含编码Capra hircus的朊病毒蛋白的基因和由载体转导的细胞。 本发明可用于制造具有多形性的细胞，其代表在韩国繁殖的Capra hircus和转导的小鼠; 可以有效地用于研究包括诊断朊病毒疾病的动物实验模型，包括山羊家族动物发生的瘙痒病，以及确认国内TSE疾病是否特异性传播。
-
7.发明公开
公开(公告)号：KR1020120075678A
公开(公告)日：2012-07-09
申请号：KR1020100137439
申请日：2010-12-29
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
CPC classification number: A61K36/73 , A23V2200/322 , A61K2236/331 , A61K2236/333
Abstract: PURPOSE: A composition containing Rubi Fructus extract is provided to inhibit modified prion production and to prevent or treat BSE. CONSTITUTION: A veterinary composition for preventing or treating BSE contains Rubi Fructus extract. The extract is prepared using water, low alcohol of C1-C4, and a mixture solvent thereof. The concentration of the extract is 6.25ug/ml. The daily dose of the composition is 0.0001-100 mg/kg. A feed additive composition for preventing or treating BSE contains the extract. A feed contains the extract.
Abstract translation: 目的：提供含有Rubi Fructus提取物的组合物，以抑制修饰的朊病毒生成并预防或治疗BSE。 组成：用于预防或治疗疯牛病的兽用组合物含有Rubi Fructus提取物。 提取物是使用水，C1-C4的低级醇及其混合溶剂制备的。 提取物的浓度为6.25ug / ml。 组合物的日剂量为0.0001-100mg / kg。 用于预防或治疗BSE的饲料添加剂组合物含有提取物。 Feed包含提取物。
-
公开(公告)号：KR101149402B1
公开(公告)日：2012-06-27
申请号：KR1020090067436
申请日：2009-07-23
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: 본 발명은 소의 PrP 펩타이드 중 특정부위를 선발하고 이를 유전자 적중 마우스에 접종하여 면역시킨 후 여기에서 분리한 면역 B 세포와 마우스 골수종유래세포를 융합하여 제조한 융합세포주; 상기 융합세포주로부터 생산되고 소해면상뇌증의 변형프리온(PrP
sc )을 소의 정상프리온 및 사슴만성소모성질병 및 스크래피(Scrapie) 등의 다른 전염성해면상뇌증의 변형프리온과 감별하여 검출해 내는 단클론항체 및 그 용도에 관한 것이다.
소해면상뇌증, 변형프리온, 단클론항체, 융합세포주, PrP 펩타이드, 전염성해면상뇌증-
公开(公告)号：KR1020110009976A
公开(公告)日：2011-01-31
申请号：KR1020090067453
申请日：2009-07-23
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: PURPOSE: A monoclonal antibody for specifically identifying and detecting abnormal prion of chronic wasting disease is provided. CONSTITUTION: A fusion cell line of deposit number KCLRF-BP-00214 produces a monoclonal antibody for detecting abnormal prion of chronic wasting disease. A method for preparing fusion cell line comprises: a step of inoculating a peptide of sequence number 1 to knock-out mouse; a step of isolating B cells from the mouse; and a step of fusing the B cells with mouse myeloma cells. The monoclonal antibody is used for detecting the abnormal prion through western blotting.
Abstract translation: 目的：提供用于特异性鉴定和检测慢性消耗性疾病异常朊病毒的单克隆抗体。 构成：融合细胞系KCLRF-BP-00214产生一种用于检测慢性消耗性疾病异常朊病毒的单克隆抗体。 制备融合细胞系的方法包括：将序列号1的肽接种到敲除小鼠的步骤; 从小鼠中分离出B细胞的步骤; 以及将B细胞与小鼠骨髓瘤细胞融合的步骤。 单克隆抗体用于通过Western印迹检测异常朊病毒。
-
10.发明授权흑염소의 프리온 단백질을 코딩하는 유전자를 포함하는 발현 벡터 및 이에 의하여 형질도입된 세포 有权表达载体，其包含来自Capra aegagrus hircus的编码朊病毒蛋白的基因和通过其转染的细胞
公开(公告)号：KR101491813B1
公开(公告)日：2015-02-16
申请号：KR1020120151209
申请日：2012-12-21
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
Abstract: 본 발명은 흑염소의 프리온 단백질을 코딩하는 유전자를 포함하는 발현 벡터 및 상기 벡터에 의해 형질도입된 세포에 관한 것으로, 이를 이용하여 국내 사육되는 흑염소를 대표하는 다형성을 가진 세포 및 형질전환 마우스를 제조할 수 있고, 염소과 동물에서 발생하는 스크래피질병(Scrapie)을 포함하는 프리온 질병의 진단을 포함하는 연구를 위한 실험동물모델 개발 및 국내 TSE 질병의 종간전파여부를 확인하는데 유용하게 이용될 수 있다.
-
-
-
-
-
-
-
-
-
Search Results
18
records
(took 0.03 seconds)
